Stem cell and drug discovery scientists around the world are using REPROCELL’s services and products in their preclinical and clinical research.

About REPROCELL

Make an inquiry

REPROCELL Corporate News (3)

REPROCELL Launch New Testing Service for Identification of the Indian (Delta) Covid-19 variant

Completion of administration of Stemchymal to all enrolled patients in phase II clinical trial in Japan

VIROCLINICS-DDL announces renewal of collaboration agreement with REPROCELL

REPROCELL will participate at the Biotechgate Digital Partnering Event.

19 April 2021 – Bioserve Biotechnologies India Pvt. Ltd. launches clinical oncology diagnostic services in India.

Launch of New Testing Service of Identification for Covid-19 Variants

REPROCELL collaborates with Blacktrace Holdings in the sales of Nadia series, single-cell analysis system, in Japan

REPROCELL Regenerative Medicine Center officially certified as a manufacturing facility for cell culture products

Hoth Therapeutics Executes Partnership Agreement with REPROCELL to Assess the Effect of HT-003 Therapeutic Platform on Inflammatory Bowel Disease

Bioserve Biotechnologies India Pvt. Ltd. launches NIPT clinical services in India

New publication on RNA reprogramming of endothelial progenitor cells to make clinically -relevant iPSCs

REPROCELL launches PCR Testing Service for COVID-19

REPROCELL completes patient registration for phase II clinical trial of regenerative therapeutic Stemchymal®

Axion BioSystems makes REPROCELL a distributor of its Maestro systems and consumables

REPROCELL launches personalized iPSC production service alongside new B2C website for "Personal iPS" customers

REPROCELL Becomes VIP Supplier on Scientist.com Biotech Marketplace

REPROCELL and VIROCLINICS-DDL Launch New Collaboration in Clinical Research

eTheRNA-led international consortium starts preclinical studies of cross-strain protective COVID-19 mRNA vaccine for high risk populations

REPROCELL announce the launch of StemRNA™ Entero human iPSC-derived intestinal epithelial cells

REPROCELL’s Personal iPS Service is Launched in Japan

Subscribe to receive updates